Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With CancerKevin C. Conlon, Thomas A. Waldmann, Thomas A. Fleisher et al.|Journal of Clinical Oncology|2014Cited by 714
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVMario Roederer, John R. Mascola, Brandon F. Keele et al.|Nature|2013Cited by 148
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D. Mason, Mario Roederer, Hugh C. Welles et al.|PLoS Pathogens|2016Cited by 78